Medullary thyroid carcinoma

Medullary thyroid carcinoma is a rare neuroendocrine malignancy arising from the calcitonin-secreting parafollicular C cells of the thyroid gland, accounting for approximately one to four percent of all thyroid cancers It affects both pediatric and adult populations, occurring either sporadically or as a hereditary component of multiple endocrine neoplasia type 2 syndromes and familial medullary thyroid carcinoma, typically driven by activating mutations in the *RET* proto-oncogene

Medullary thyroid carcinoma is a rare neuroendocrine malignancy arising from the calcitonin-secreting parafollicular C cells of the thyroid gland, accounting for approximately one to four percent of all thyroid cancers Pathophysiologically, the tumor is characterized by elevated serum calcitonin and carcinoembryonic antigen levels, an early propensity for regional lymph node metastasis, and an insensitivity to radioactive iodine or thyroid-stimulating hormone suppression due to its distinct non-...

Medullary thyroid carcinoma is a rare neuroendocrine malignancy arising from the calcitonin-secreting parafollicular C cells of the thyroid gland, accounting for approximately one to four percent of all thyroid cancers Pathophysiologically, the tumor is characterized by elevated serum calcitonin and carcinoembryonic antigen levels, an early propensity for regional lymph node metastasis, and an insensitivity to radioactive iodine or thyroid-stimulating hormone suppression due to its distinct non-...

It affects both pediatric and adult populations, occurring either sporadically or as a hereditary component of multiple endocrine neoplasia type 2 syndromes and familial medullary thyroid carcinoma, typically driven by activating mutations in the *RET* proto-oncogene

It affects both pediatric and adult populations, occurring either sporadically or as a hereditary component of multiple endocrine neoplasia type 2 syndromes and familial medullary thyroid carcinoma, typically driven by activating mutations in the *RET* proto-oncogene

Pathophysiologically, the tumor is characterized by elevated serum calcitonin and carcinoembryonic antigen levels, an early propensity for regional lymph node metastasis, and an insensitivity to radioactive iodine or thyroid-stimulating hormone suppression due to its distinct non-follicular cell lineage